Neo Ivy Capital Management Nuvasive Inc Transaction History

Neo Ivy Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$47.19 - $62.68 $74,135 - $98,470	-1,571 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$56.91 - $67.81 $45,129 - $53,773	793 Added 101.93%	1,571 $87,000
Q2 2021 Aug 16, 2021	BUY	$64.02 - $71.72 $49,807 - $55,798	778 New	778 $53,000
Q2 2020 Aug 17, 2020	SELL	$43.51 - $66.59 $68,354 - $104,612	-1,571 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$43.51 - $66.59 $9,659 - $14,782	222 Added 16.46%	1,571 $87,000
Q1 2020 May 15, 2020	BUY	$32.82 - $81.13 $44,274 - $109,444	1,349 New	1,349 $68,000
Q2 2019 Aug 15, 2019	SELL	$53.69 - $65.47 $429 - $523	-8 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$44.53 - $58.9 $436,705 - $577,632	-9,807 Reduced 99.92%	8 $0
Q4 2018 Feb 14, 2019	BUY	$47.64 - $71.26 $467,586 - $699,416	9,815 New	9,815 $486,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.